U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
                                   ACT OF 1934

                  For the quarterly period ended April 30, 2005

    [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
                              EXCHANGE ACT OF 1934

                         For the transition period from

                         Commission File No. 000-51509

                                 Elite Cosmetics, Inc.
        (Exact name of small business issuer as specified in its charter)

       Delaware
(State or other jurisdiction of                             (I.R.S. Employer
incorporation or organization)                              Identification No.)

                             107 St. Patrick's Street
                            Donaldsonville, Louisiana 70346
                    (Address of Principal Executive Offices)

                                 225/473-7578
                           (Issuer's telephone number)

                                    EDMONDS 4, INC.
                             300 Park Avenue, #1700
                            New York, New York 10022
      (Former name, address and fiscal year, if changed since last report)

Check  whether  the issuer  (1) has filed all  reports  required  to be filed by
Section 13 or 15(d) of the Exchange  Act during the  preceding 12 months (or for
such shorter period that the issuer was required to file such reports),  and (2)
has been subject to such filing  requirements for the past 90 days.
Yes [X] No [ ]


Check whether the registrant has filed all documents and reports  required to be
filed by  Sections  12,  13,  or 15(d) of the  Exchange  Act  subsequent  to the
distribution of securities under a plan confirmed by a court. Yes [X] No [ ]

State the number of shares outstanding of each of the issuer's classes of common
equity, as of June 16, 2005: 28,870,000 shares of common stock.

<PAGE>

                              Elite Cosmetics, Inc.
                          (a development stage company)

                              FINANCIAL STATEMENTS

                                      INDEX


Part I-- FINANCIAL INFORMATION

  Item 1. Financial Statements

  Item 2. Management's Discussion and Analysis of Financial Condition

  Item 3. Control and Procedures

Part II-- OTHER INFORMATION

  Item 1. Legal Proceedings

  Item 2. Changes in Securities

  Item 3. Defaults Upon Senior Securities

  Item 4. Submission of Matters to a Vote of Security Holders

  Item 5. Other Information

  Item 6. Exhibits and Reports on Form 8-K

Signature

<PAGE>


Item 1. Financial Information

BASIS OF PRESENTATION

The accompanying  reviewed financial statements are presented in accordance with
U.S. generally accepted accounting  principles for interim financial information
and the  instructions  to Form 10-QSB and item 310 under subpart A of Regulation
S-B.  Accordingly,  they do not include  all of the  information  and  footnotes
required by generally  accepted  accounting  principles  for complete  financial
statements.  In the opinion of management,  all adjustments  (consisting only of
normal occurring accruals)  considered  necessary in order to make the financial
statements not  misleading,  have been included.  Operating  results for the six
months ended April 30, 2005 are not  necessarily  indicative of results that may
be expected for the year ending October 31, 2005.  The financial  statements are
presented on the accrual basis.


<PAGE>





                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                              FINANCIAL STATEMENTS
                              AS OF APRIL 30, 2005
                                   (UNAUDITED)



<PAGE>



                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)



                                    CONTENTS


PAGE            1       CONDENSED BALANCE SHEET AS OF APRIL 30, 2005 (UNAUDITED)

PAGE            2       CONDENSED STATEMENTS OF OPERATIONS FOR THE THREE AND SIX
                        MONTHS  ENDED  APRIL 30,  2005 AND FOR THE  PERIOD  FROM
                        AUGUST  19,   2004   (INCEPTION)   TO  APRIL  30,   2005
                        (UNAUDITED)

PAGE            3       CONDENSED  STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
                        FOR THE PERIOD FROM AUGUST 19, 2004 (INCEPTION) TO APRIL
                        30, 2005 (UNAUDITED)

PAGE            4       CONDENSED  STATEMENTS  OF CASH  FLOWS FOR THE SIX MONTHS
                        ENDED  APRIL 30, 2005 AND FOR THE PERIOD FROM AUGUST 19,
                        2004 (INCEPTION) TO APRIL 30, 2005 (UNAUDITED)

PAGES        5 - 7      NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)

<PAGE>

                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                             CONDENSED BALANCE SHEET
                              AS OF APRIL 30, 2005
                                   (UNAUDITED)

<TABLE>
<CAPTION>

                                                     ASSETS

<S>                                                                                    <C>
CURRENT ASSETS
  Cash                                                                             $        4,500
                                                                                   ---------------

TOTAL ASSETS                                                                       $        4,500
                                                                                   ===============

                                      LIABILITIES AND STOCKHOLDERS' EQUITY

TOTAL LIABILITIES                                                                  $            -

STOCKHOLDERS' EQUITY
  Common stock, $0.0001 par value, 100,000,000 shares authorized, 28,650,000 shares
   issued and outstanding                                                                   2,865
  Additional paid in capital                                                              854,485
  Accumulated deficit during development stage                                           (852,850)
                                                                                   ---------------
        Total Stockholders' Equity                                                          4,500
                                                                                   ---------------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                                         $        4,500
                                                                                   ===============
</TABLE>

            See accompanying notes to condensed financial statements.

                                        1
<PAGE>


                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                       CONDENSED STATEMENTS OF OPERATIONS
                                   (UNAUDITED)


<TABLE>
<CAPTION>


                                                       For the Three Months       For the Six Months     For the Period From
                                                                                                            August 19, 2004
                                                                Ended                     Ended           Inception) to April
                                                           April 30, 2005            April 30, 2005           30, 2005
                                                        ------------------        ------------------       ------------------

<S>                                                            <C>                       <C>                          <C>
    OPERATING EXPENSES
      Stock compensation                                $        852,000          $         852,000        $         852,000
      General and administrative                                       -                        250                      850
                                                        ------------------        ------------------       ------------------
            Total Operating Expenses                             852,000                    852,250                  852,850
                                                        ------------------        ------------------       ------------------

    LOSS FROM OPERATIONS                                        (852,000)                  (852,250)                (852,850)

    Provision for Income Taxes                                         -                          -                        -
                                                        ------------------        ------------------       ------------------

    NET LOSS                                            $       (852,000)         $        (852,250)       $        (852,850)
                                                        ==================        ==================       ==================

     Net loss per share - basic and diluted             $          (0.85)   `                 (0.85)       $           (0.85)
                                                        ======================    ==================       ==================

    Weighted average number of shares outstanding
     during the period - basic and diluted                     1,007,528                  1,003,702                1,002,638
                                                        ======================    ==================       ==================
</TABLE>


            See accompanying notes to condensed financial statements.


                                        2
<PAGE>



                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                  CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY
        FOR THE PERIOD FROM AUGUST 19, 2004 (INCEPTION) TO APRIL 30, 2005
                                   (UNAUDITED)

<TABLE>
<CAPTION>

                                                                                                  Accumulated
                                                                                Additional       Deficit During
                                                  Common Stock                  Paid-In          Development
                                            Shares            Amount            Capital              Stage               Total
                                       ----------------  ----------------    ----------------   ----------------  ----------------
<S>                                        <C>                  <C>                <C>                <C>               <C>
Stock issued to founders for expenses
 ($0.0001 per share)                           100,000   $            10     $            90    $             -   $           100

Net loss for the period from August 19,
 2004 (inception) to October 31, 2004                -                 -                   -               (600)             (600)
                                       ----------------  ----------------    ----------------   ----------------  ----------------

Balance, October 31, 2004                      100,000                10                  90              (600)              (500)

Common stock issued for services
 ($0.03 per share)                          28,400,000             2,840             849,160                  -           852,000

Common stock issued for cash
 ($0.03 per share)                             150,000                15               4,485                  -             4,500

In-kind contribution                                 -                 -                 750                  -               750

Net loss for the six months
 ended April 30, 2005                                -                 -                   -           (852,250)         (852,250)
                                       ----------------  ----------------    ----------------   ----------------  ----------------

BALANCE, APRIL 30, 2005                     28,650,000   $         2,865     $       854,485           (852,850)            4,500
                                       ================  ================    ================   ================  ================
</TABLE>

            See accompanying notes to condensed financial statements.


                                        3
<PAGE>

                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                       CONDENSED STATEMENTS OF CASH FLOWS
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                                              For the Six Months         For the Period From
                                                                                                           August 19, 2004
                                                                                    Ended                   (Inception) to
                                                                                April 30, 2005              April 30, 2005
                                                                             ---------------------       ---------------------

<S>                                                                                  <C>                          <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
  Net loss                                                                   $           (852,250)       $           (852,850)
  Adjustments to reconcile net loss to net cash used in operating
   activities:
    Stock compensation                                                                    852,000                     852,100
    In-kind contribution                                                                      750                         750
   Changes in operating assets and liabilities:
    Decrease in accounts payable                                                             (500)                          -
                                                                             ---------------------       ---------------------
         Net Cash Used In Operating Activities                                                  -                           -
                                                                             ---------------------       ---------------------

CASH FLOWS FROM INVESTING ACTIVITIES                                                            -                           -
                                                                             ---------------------       ---------------------

CASH FLOWS FROM FINANCING ACTIVITIES:
  Proceeds from issuance of common stock                                                    4,500                       4,500
                                                                             ---------------------       ---------------------
         Net Cash Provided By Financing Activities                                          4,500                       4,500
                                                                             ---------------------       ---------------------

NET INCREASE IN CASH                                                                        4,500                       4,500

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD                                                -                           -
                                                                             ---------------------       ---------------------

CASH AND CASH EQUIVALENTS AT END OF PERIOD                                   $              4,500      $                4,500
                                                                             =====================       =====================
</TABLE>


            See accompanying notes to condensed financial statements.


                                        4
<PAGE>

                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                     NOTES TO CONDENSED FINANCIAL STATEMENTS
                              AS OF APRIL 30, 2005
                                   (UNAUDITED)


NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION

     (A) Basis of Presentation

     The  accompanying   unaudited  condensed  financial  statements  have  been
     prepared in accordance with accounting principles generally accepted in The
     United States of America and the rules and  regulations  of the  Securities
     and Exchange  Commission for interim  financial  information.  Accordingly,
     they do not  include  all the  information  necessary  for a  comprehensive
     presentation of financial position and results of operations.

     It  is  management's   opinion,   however  that  all  material  adjustments
     (consisting  of normal  recurring  adjustments)  have  been made  which are
     necessary for a fair financial statements presentation. The results for the
     interim period are not necessarily indicative of the results to be expected
     for the year.

     During  2005,  the Company  changed its name from  Edmonds 4, Inc. to Elite
     Cosmetics, Inc. to better reflect its current business operations.

     (B) Organization

     Elite Cosmetics,  Inc. F/K/A Edmonds 4, Inc. (a development  stage company)
     (the  "Company") was  incorporated  in Delaware on August 19, 2004, and has
     elected a fiscal year end of October 31.

     The  Company  plans to market a lime of  women's'  cosmetics.  The  Company
     intends to market its products  directly to consumers  through a variety of
     direct marketing channels.

     Activities  during the development  stage include  developing the corporate
     infrastructure, implementing the business plan, and raising capital.

     (C) Use of Estimates

     In preparing  financial  statements in conformity  with generally  accepted
     accounting  principles,  management  is  required  to  make  estimates  and
     assumptions  that affect the reported amounts of assets and liabilities and
     the  disclosure of  contingent  assets and  liabilities  at the date of the
     financial  statements and revenues and expenses during the reported period.
     Actual results could differ from those estimates.

                                       5
<PAGE>
     (D) Loss Per Share

     Basic and  diluted  net loss per common  share is  computed  based upon the
     weighted  average  common  shares   outstanding  as  defined  by  Financial
     Accounting  Standards No. 128,  "Earnings Per Share." As of April 30, 2005,
     there were no common share equivalents outstanding.

     (E) Business Segments

     The Company  operates in one segment and therefore  segment  information is
     not presented.

     (F) Income Taxes

     The Company  accounts  for income  taxes under the  Statement  of Financial
     Accounting  Standards Board Statement of Financial Accounting Standards No.
     109,  "Accounting for Income Taxes" ("Statement 109"). Under Statement 109,
     deferred  tax  assets and  liabilities  are  recognized  for the future tax
     consequences  attributable to differences  between the financial  statement
     carrying  amounts of existing assets and  liabilities and their  respective
     tax bases.  Deferred tax assets and  liabilities are measured using enacted
     tax rates  expected to apply to taxable  income in the years in which those
     temporary  differences  are  expected to be  recovered  or  settled.  Under
     Statement  109,  the effect on  deferred  tax assets and  liabilities  of a
     change in tax rates is recognized in income in the period that includes the
     enactment date.

NOTE 2 STOCKHOLDERS' EQUITY

     (A) Common Stock Issued for Cash

     During April 2005,  the Company  issued  150,000  shares of common stock to
     individuals for cash of $4,500 ($0.03 per share).

     (B) Stock Issued for Services

     During  2004,  the Company  issued  100,000  shares of common  stock to its
     founder for payment of $100 in expenses ($0.0001 per share).

     During 2005,  the Company issued  28,400,000  shares of common stock to its
     principal  stockholder for services valued at $852,000 based on recent cash
     offering prices ($0.03 per share) (See Note 3).

                                       6
<PAGE>

     (D) In-Kind Contribution

     During  2005,  the  principal  stockholder  of the  Company  paid  $750  of
     operating expenses on behalf of the Company (See Note 3).

NOTE 3 RELATED PARTY TRANSACTIONS

     A principal  stockholder  of the Company paid $750 of expenses on behalf of
     the Company from inception (See Note 2).

     During 2005,  the Company issued  28,400,000  shares of common stock to its
     principal  stockholder for services valued at $852,000 based on recent cash
     offering prices ($0.03 per share) (See Note 2).

NOTE 4 GOING CONCERN

     As reflected in the accompanying  financial  statements,  the Company is in
     the development  stage with no operations.  This raises  substantial  doubt
     about its  ability  to  continue  as a going  concern.  The  ability of the
     Company to  continue  as a going  concern  is  dependent  on the  Company's
     ability to raise  additional  capital and implement its business  plan. The
     financial statements do not include any adjustments that might be necessary
     if the Company is unable to continue as a going concern.

     Management believes that actions presently being taken to obtain additional
     funding and implement its strategic  plans provide the  opportunity for the
     Company to continue as a going concern.

NOTE 5 SUBSEQUENT EVENT

     During May 2005,  the  Company  issued  220,000  shares of common  stock to
     individuals for cash of $6,600 ($0.03 per share).

                                       7
<PAGE>
Item 2. Management's Discussion and Analysis of Financial Conditions and Results
        of Operations

Plan of Operation

On March  25,  2005 (the  "Effective  Date"),  pursuant  to the terms of a Stock
Purchase  Agreement,  Glen  Landry  purchased  100,000  shares of our issued and
outstanding common stock from Richard Neussler,  the sole officer,  director and
shareholder  of the Company.  Glen Landry was  appointed  our  President,  Chief
Executive  Officer,  Chief  Financial  Officer,  and  Chairman  of the  Board of
Directors.  As a result of this change in control,  we have changed our business
plan to the production of cosmetics and creams.  Specifically  we will begin the
development and production of an under-eye cream that will  dramatically  reduce
the signs of aging,  such as lines and  puffiness.  The Company  will pursue the
development  of other  cosmetic  products  in the future.  On April 8, 2005,  we
amended our  Articles of  Incorporation  to change our name to Elite  Cosmetics,
Inc.

In April 2005,  we conducted a private  placement  offering  and issued  150,000
shares of common stock at a purchase price of $0.03 per share to individuals for
total cash of $4,500.  In May we finalized the offering by selling an additional
220,000  shares  of  common  stock at a  purchase  price of $0.03  per  share to
individuals for total cash of $6,600.  In total in this offering we sold a total
of 370,000 shares at $0.03 per share for a total of $11,100.

Results of Operation

We did not have any operating  income from  inception  (August 19, 2004) through
April 30, 2005 and during this period we  recognized a net loss of $852,850.  We
have had no general and  administrative  expenses from  inception.  Our expenses
from inception were comprised of stock compensation paid to our sole officer and
director.

Liquidity and Capital Resources

At April 30, 2005 the Company had $4,500 in cash and total assets, and will rely
upon the  issuance of common stock and  additional  capital  contributions  from
shareholders to fund  administrative  expenses  pending the  commencement of our
operations.


                                       8
<PAGE>

Item 3. Controls and Procedures

(a)  Evaluation of disclosure controls and procedures.

Our Chief  Executive  Officer  and Chief  Financial  Officer  (collectively  the
"Certifying  Officers")  maintain a system of disclosure controls and procedures
that is designed to provide  reasonable  assurance  that  information,  which is
required to be disclosed,  is accumulated and communicated to management timely.
Under the supervision and with the  participation of management,  the Certifying
Officers  evaluated  the  effectiveness  of  the  design  and  operation  of our
disclosure  controls and  procedures  (as defined in Rule  [13a-14(c)/15d-14(c)]
under the Exchange  Act) within 90 days prior to the filing date of this report.
Based  upon  that  evaluation,   the  Certifying  Officers  concluded  that  our
disclosure  controls and  procedures  are  effective in timely  alerting them to
material  information  relative to our company  required to be  disclosed in our
periodic filings with the SEC.

(b)  Changes in internal controls.

Our Certifying  Officer has indicated that there were no significant  changes in
our  internal  controls  or  other  factors  that  could  affect  such  controls
subsequent to the date of his evaluation, and there were no such control actions
with regard to significant deficiencies and material weaknesses.

                           PART II - OTHER INFORMATION

Item 1.   Legal Proceedings.

          We are currently not a party to any pending legal  proceedings  and no
          such  action by, or to the best of its  knowledge,  against the us has
          been threatened.

Item 2.   Changes in Securities.

          None

Item 3.   Defaults Upon Senior Securities.

          None

Item 4.   Submission of Matters to a Vote of Security
          Holders.

          No matter was  submitted  during the quarter  ending  April 30,  2005,
          covered  by this  report to a vote of our  shareholders,  through  the
          solicitation of proxies or otherwise.

Item 5.   Other Information.

          None

Item 6.   Exhibits and Reports of Form 8-K.

          (a)  Exhibits

          31.1 Certification pursuant to Section 302 of Sarbanes Oxley Act
               of 2002

          32.1 Certification pursuant to Section 906 of Sarbanes Oxley Act
               of 2002

          (b) Reports of Form 8-K

              On April 5, 2005, we filed a Form 8-K pursuant to a change
              in control.


                                       9

<PAGE>


                                   SIGNATURES

In  accordance  with  Section 13 or 15(d) of the Exchange  Act,  the  registrant
caused  this  report to be signed on its behalf by the  undersigned,  there unto
duly authorized.

                                 Elite Cosmetics, Inc.


Date: June 16, 2005              By: /s/ Glen Landry
                                 ----------------------
                                 Glen Landry
                                 President, CEO and CFO



                                       10